Positive study enables valuable repositioning of new antifibrotic drug candidates by a growing number of pharma companies SAN DIEGO, Oct. 17, 2024 /PRNewswire/ -- MeCo Diagnostics, a venture-backed startup dedicated to unlocking a new therapeutic modality for cancer, has announced a...
Landmark Phase 2 study demonstrates the first successful clinical application of antifibrotic therapy for breast cancer
Seaking AlphaSeeking Alpha / Seaking Alpha 22 hours ago 1 Views
Comments